Lack of Pharmacokinetic Interaction for ISIS 113715, a 2′- 0 -Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone

Author: Geary Richard S.  

Publisher: Adis International

ISSN: 0312-5963

Source: Clinical Pharmacokinetics, Vol.45, Iss.8, 2006-01, pp. : 789-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract